Skip to main content

Table 1 Participant demographics and other characteristics

From: Understanding the role of scientific evidence in consumer evaluation of natural health products for osteoarthritis an application of the means end chain approach

Item

Everyone (N = 25)

High (N = 13)

Low (N = 12)

p-value

Gender

19 (76)

10 (77)

9 (75)

1a

Female, N (%)

Mean Age in years (range)

58.8 (42–78)

55.08 (42–78)

62.92 (43–78)

0.100 b

Ethnicity, N (%)

   

0.422b

North American

10 (40)

6 (46)

4 (40)

 

European

13 (52)

5 (38)

8 (62)

 

Other

6 (24)

4 (67)

2 (33)

 

At least some college as highest education, N (%)

15 (60)

9 (69)

6 (50)

0.428a

Annual household net income less than $50,000 d N (%)

14 (56)

7 (54)

7 (58)

1a

Have Extended health insurance, N (%)

12 (48)

6 (46)

6 (50)

1a

Use of NHPs to treat Osteoarthritis longer than 6 months N (%)

21 (84)

9 (69)

12 (100)

0.096 a

Mean importance of scientific evidence rating (0 = unimportant, 10 = very important) (standard deviation)

8 (2.3)

8 (2.6)

7.9 (2.1)

0.931c

Mean overall health rating (0 = worst, 10 = best) (standard deviation)

7.2 (1.2)

7.0 (1)

7.5 (1.4)

0.322 c

Mean pain scale visual analogue scale, 0 = worst, 10 = best (standard deviation)

6.7 (1.8)

6.2 (2.0)

6.9 (1.6)

0.328c

Joints affected d N (%)

Upper extremity

4 (21)

1 (10)

3 (33)

0.270b

Lower extremity

12 (63)

8 (80)

4 (44)

 

Other

3 (16)

1 (10)

2 (22)

 

Total joints affected

19 (100)

10 (100)

9 (100)

 

Recruitment location b – N (%)

Senior community centre

5 (20)

1 (20)

4 (80)

0.2505 b

Online community website

17 (68)

11 (65)

6 (35)

 

Health food store

2 (8)

1 (50)

1 (50)

 

Natural Health Products Used – N (%)

Glucosamine

25 (100)

13 (100)

12 (100)

 

Chondroitin e

18 (72)

8 (62)

10 (83)

 

MSM

0 (0)

0 (0)

10 (83)

 

Bromelain

4 (16)

0 (0)

4 (33)

 
  1. Caption: a: Fisher test, b: Chi-square test, c: unpaired t-test; d: four participants did not indicate their income; e: chondroitin products were almost always in combination with glucosamine. All tests were performed using Prism GraphPad version 5.0 for Windows. Participants could indicate more than one anatomical joint; five participants did not indicate an affected anatomical joint.